Search Results - Novartis,

Novartis: The Challenge of Success (A)

Authors: Sandra J. Sucher Stacy McManus

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

Novartis' Sandoz: Between Generics and Pharma

Authors: Carin-Isabel Knoop Krishna G. Palepu

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

)2124-الأتمتة الكاملة كأداة لتحقيق إستدامة الصناعة الدوائية دراسة حالة شركة نوفارتيس) 210

Alternate Title: Full Automation as a Tool for Achieving Pharmaceutical Industry Sustainability: A Case Study of Novartis (2015-2024).

Authors: جعفر سعدي محمد علي دشه

Source: Journal of Economics of Business & Finance. Jun2026, Vol. 10 Issue 2, p282-294. 13p.

Novartis Heart-Drug Failure Deepens Setbacks, Hits Rivals.

Authors: Kinzelmann, Fabienne Hipwell, Deirdre

Source: Bloomberg.com. 9/7/2026, pN.PAG-N.PAG. 1p.

Novartis Sees Avidity Drug Fail in Third Setback in a Week.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 9/8/2026, pN.PAG-N.PAG. 1p.

Novartis Heart-Drug Flop Deepens Pipeline Setbacks, Hits Rivals.

Authors: Kinzelmann, Fabienne Hipwell, Deirdre

Source: Bloomberg.com. 9/7/2026, pN.PAG-N.PAG. 1p.

Novartis Pauses Autoimmune Drug Trials as Three Patients Die.

Authors: Kinzelmann, Fabienne Muller, Madison Furlong, Ashleigh

Source: Bloomberg.com. 9/1/2026, pN.PAG-N.PAG. 1p.

Novartis Profit Beats Estimates, Pointing to Growth.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 7/21/2026, pN.PAG-N.PAG. 1p.

Novartis Profit Beats Estimates, Signals Return to Growth.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 7/21/2026, pN.PAG-N.PAG. 1p.

Novartis Pharma: The Business Unit Model

Authors: Carin-Isabel Knoop Cate Reavis Srikant M. Datar

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

Novartis Heart Drug Failure Rattles Market for Rival Treatments.

Authors: Muller, Madison Kinzelmann, Fabienne Furlong, Ashleigh

Source: Bloomberg.com. 9/9/2026, pN.PAG-N.PAG. 1p.

Novartis Avidity Drug Fails in Third Trial Setback in a Week.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 9/8/2026, pN.PAG-N.PAG. 1p.

MarketLine Company Profile: Novartis AG.

Source: Novartis AG MarketLine Company Profile. 3/23/2026, p1-76. 76p.

Novartis Profit, Sales Decline as Generic Competition Bites.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 4/28/2026, pN.PAG-N.PAG. 1p.

Novartis (A): Being a Global Leader

Authors: Carin-Isabel Knoop Srikant M. Datar

Resource Type: eBook.

Categories: BUSINESS & ECONOMICS / General

European Stocks Muted as Novartis Shares Fall Most on Record.

Authors: Standring, Will (AUTHOR)

Source: Bloomberg.com. 9/8/2026, pN.PAG-N.PAG. 1p.

European Stocks Muted as Brent Climbs; Novartis Shares Plunge.

Authors: Standring, Will (AUTHOR)

Source: Bloomberg.com. 9/8/2026, pN.PAG-N.PAG. 1p.

European Stocks Drop as Brent Climbs; Novartis Shares Plunge 10%.

Authors: Standring, Will (AUTHOR)

Source: Bloomberg.com. 9/8/2026, pN.PAG-N.PAG. 1p.

European Stocks Slip as Brent Climbs; Novartis Shares Plunge 10%.

Authors: Standring, Will (AUTHOR)

Source: Bloomberg.com. 9/8/2026, pN.PAG-N.PAG. 1p.

European Stocks Muted as Oil Prices Climb and Novartis Falls.

Authors: Stamm, Levin Standring, Will

Source: Bloomberg.com. 9/7/2026, pN.PAG-N.PAG. 1p.